Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT02750852
NCT02750852UnknownNot Applicable

An Algorithm for Predicting Blood Loss and Transfusion Risk in Fast Track Total Hip Arthroplasty

Azienda Ospedaliera Bolognini di Seriate Bergamo0 sites124 target enrollmentStarted: April 2016Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
124
Primary Endpoint
Create an algorithm to predict blood loss after total hip arthroplasty
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Aim of these study is to create an algorithm, using data from patients that undergoing total hip arthroplasty, to predict blood loss after surgery and permit a safe domestic discharge.

Detailed Description

Two different cohorts of patients undergoing total hip arthroplasty will be analyzed to obtain data about hemoglobin trends. The first group will be used to obtain the algorithm, the second one to validate results of the first group, determining sensitivity and specificity.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross Sectional

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with hip arthritis

Exclusion Criteria

  • •ASA 4 - 5
  • •Active treatment with warfarin
  • •Coagulation disorders

Outcomes

Primary Outcomes

Create an algorithm to predict blood loss after total hip arthroplasty

Time Frame: 3 months

Data from the fist cohort of patients have been collected and analyzed to obtain an algorithm describing the trends of hemoglobin values after total hip arthroplasty. These algorithm was after applied to patients of a second cohort of consecutive patients undergoing total hip arthroplasty to determine specificity and sensitivity.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Azienda Ospedaliera Bolognini di Seriate Bergamo
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Riccardo Compagnoni

Medical doctor

Azienda Ospedaliera Bolognini di Seriate Bergamo

Similar Trials

Completed
Not Applicable
Development of a Predictive Algorithm for a Hemoglobin Value of Less Than 10 g/dl Postoperatively in Scheduled Hip or Knee ArthroplastyHip Prosthetic SurgeryKnee Prosthetic Surgery
NCT05605860Fondation Hôpital Saint-Joseph1,041
Completed
Not Applicable
Method for Improved Intraoperative Blood Loss EstimatesImproved Intraoperative Blood Loss Estimates
NCT01634828University of Utah47
Unknown
Not Applicable
To Establish a Blood Transfusion Prediction Model for Liver Transplantation Patients Based on PBMBlood Transfusion Complication
NCT03814772The Third Xiangya Hospital of Central South University2,000
Unknown
Not Applicable
Blood Transfusion Among Patients With Pelvic Fracture in ChinaPelvic FractureBlood Transfusion ComplicationTransfusion Reaction
NCT03855644The Third Xiangya Hospital of Central South University2,000
Completed
Not Applicable
An Algorithm for Intra-operative Goal-directed Haemodynamic Management in Non-cardiac SurgeryFracture of Surgical Neck of HumerusColonic TumorStage IIIB Ovarian CarcinomaNeoplasm of Head of Pancreas
NCT01384097Charite University, Berlin, Germany774
An Algorithm for Predicting Blood Loss and... | Clinical Trial